NFATC3 and neoplasm: Considering the expression level of LINC00423 was reduced by around 1- to 2-fold (p < 0.05) in retroperitoneal sarcoma tissues compared to healthy tissues, and it suppressed the MAPK pathway and destabilized NFATC3 to halt liposarcoma growth in vitro and in vivo, LINC00423, therefore, is likely to play a tumour-repressing role in the progression of liposarcoma [28].